Literature DB >> 31912354

Minimally invasive anterior foraminotomy for cervical radiculopathy: how I do it.

Rodolfo Maduri1, Lukas Bobinski2, John Michael Duff3.   

Abstract

BACKGROUND: The standard treatment for cervical radiculopathy is anterior discectomy and fusion. The authors describe a minimally invasive anterior cervical foraminotomy as a surgical option for direct nerve root decompression in cervical radiculopathy.
METHOD: Through a modified Smith-Robinson approach, the prevertebral fascia is mobilized laterally, displacing the sympathetic chain with it. A thumbnail size portion of the longus colli muscle is removed. A tubular retractor is placed, centered over the index uncovertebral joint. The lateral part of the joint is progressively drilled towards the foramen. After exposure of the intervertebral foramen, the perivascular ligamentous tissue is opened. Removal of disc fragments and osteophytes allows direct visualization and direct decompression of the nerve root.
CONCLUSION: Anterior cervical foraminotomy is a safe "motion preserving" procedure for direct nerve decompression in selected patients with cervical radiculopathy that does not require cervical fusion.

Entities:  

Keywords:  ACDF; Cervical disc; Cervical fusion; Cervical herniation; Cervical radiculopathy; Disc herniation; Spondylopathy

Year:  2020        PMID: 31912354     DOI: 10.1007/s00701-019-04201-y

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  2 in total

1.  Comparative Analysis of the Biomechanical Characteristics After Different Minimally Invasive Surgeries for Cervical Spondylopathy: A Finite Element Analysis.

Authors:  Tao He; Jun Zhang; Tong Yu; Jiuping Wu; Tianyang Yuan; Rui Liu; Zhihe Yun; Haorui Du; Le Qi; Junyan An; Wu Xue; Xinyu Nie; Qinyi Liu
Journal:  Front Bioeng Biotechnol       Date:  2021-12-16

2.  The CT assessment of uncovertebral joints degeneration in a healthy population.

Authors:  Tianji Huang; Jie Qin; Weiyang Zhong; Ke Tang; Zhengxue Quan
Journal:  Eur J Med Res       Date:  2021-12-13       Impact factor: 2.175

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.